Abliva AB NPV
Sell:5.92pBuy:5.92p
No change
Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:5.92p
Buy:5.92p
Change:No change
No changePrices delayed by at least 15 minutes
Sell:5.92p
Buy:5.92p
Change:No change
No changePrices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 7 March 2025 | Eskil ElmerChief Level Officer | Sell Regular sell transaction (market) | 574,978 | 0.45 SEK | 258,740.10 SEK | 0 |
| 10 February 2025 | David Laskow-PooleyChairman of the Board | Sell Regular sell transaction (market) | 1,000,000 | 0.05 SEK | 54,000.00 SEK | 0 |
| 10 February 2025 | David Laskow-PooleyChairman of the Board | Sell Regular sell transaction (market) | 2,250,000 | 0.45 SEK | 1,012,500.00 SEK | 45,828 |
| 7 February 2025 | Magnus HanssonChief Level Officer | Sell Regular sell transaction (market) | 2,000,000 | 0.05 SEK | 108,000.00 SEK | 0 |
| 7 February 2025 | Eskil ElmerChief Level Officer | Sell Regular sell transaction (market) | 1,750,000 | 0.05 SEK | 94,500.00 SEK | 0 |
| 7 February 2025 | Magnus HanssonChief Level Officer | Sell Regular sell transaction (market) | 3,000,000 | 0.03 SEK | 90,000.00 SEK | 0 |
| 7 February 2025 | Catharina Janzon JohanssonCFO | Sell Regular sell transaction (market) | 2,000,000 | 0.05 SEK | 108,000.00 SEK | 0 |
| 7 February 2025 | Catharina Janzon JohanssonCFO | Sell Regular sell transaction (market) | 3,000,000 | 0.03 SEK | 90,000.00 SEK | 0 |
| 7 February 2025 | David Olof Rikard BejkerIndependent Director | Sell Regular sell transaction (market) | 1,000,000 | 0.05 SEK | 54,000.00 SEK | 0 |
| 7 February 2025 | David Olof Rikard BejkerIndependent Director | Sell Regular sell transaction (market) | 1,500,000 | 0.04 SEK | 54,000.00 SEK | 0 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 7 February 2025 | PHARMING GROUP NVParent Company | Buy Regular purchase transaction | 1,413,841,472 | 0.45 SEK | 636,228,662.40 SEK | 1,413,841,472 |
| 7 February 2025 | HADEAN VENTURES ASVenture Capital | Sell Regular sell transaction (market) | 283,108,739 | 0.45 SEK | 127,398,932.55 SEK | 0 |
| 7 February 2025 | HADEAN VENTURES ASVenture Capital | Sell Regular sell transaction (market) | 127,448,607 | 0.45 SEK | 57,351,873.15 SEK | 283,108,739 |
| 7 February 2025 | Ellen K. DonnellyCEO | Sell Regular sell transaction (market) | 2,493,402 | 0.45 SEK | 1,122,030.90 SEK | 0 |
| 10 February 2025 | David Laskow-PooleyChairman of the Board | Sell Regular sell transaction (market) | 2,250,000 | 0.45 SEK | 1,012,500.00 SEK | 45,828 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.